Coffee consumption and prostate cancer risk: A meta-analysis of cohort studies

Nutrition and Cancer

Volumn 67, Issue 3, 2015, Pages 392-400

  Liu, Huan ^a,b   Hu, Guang Hui ^a   Wang, Xing Chun ^b   Huang, Tian Bao ^a,b   Xu, Liang ^a   Lai, Peng ^a   Guo, Zhui Feng ^a   Xu, Yun Fei ^a  

^a TONGJI UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; COFFEE; COHORT ANALYSIS; DOSE RESPONSE; FOOD INTAKE; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PROSTATE CANCER; RISK ASSESSMENT; META ANALYSIS; PROSTATIC NEOPLASMS; PUBLISHING; RISK;

COFFEE;

COFFEE; COHORT STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; PUBLICATION BIAS; RISK;

EID: 84926521085     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1004727     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61, 69-90, 2011. doi:10.3322/caac.20107
2. Wilson KM, Giovannucci EL, and Mucci LA: Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 14, 365-74, 2012. doi:10.1038/aja.2011.142
3. Yu H, Harris RE, Gao YT, Gao R, and Wynder EL: Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20, 76-81, 1991.
4. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, et al.: Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40, 1155-1163, 2002.
5. Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, et al.: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134, 562-567, 2004.
6. Gomez-Ruiz JA, Leake DS, and Ames JM: In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55, 6962-9, 2007. doi:10.1021/jf0710985
7. Cardenas C, Quesada AR, and Medina MA: Anti-Angiogenic and antiinflammatory properties of kahweol, a coffee diterpene. PLoS One 6, e23407, 2011. doi:10.1371/journal.pone.0023407
8. Park CH, Myung SK, Kim TY, Seo HG, Jeon YJ, et al.: Coffee consumption and risk of prostate cancer: a meta-Analysis of epidemiological studies. BJU Int 106, 762-769, 2010. doi:10.1111/j.1464-410X.2010.09493.x
9. Yu X, Bao Z, Zou J, and Dong J: Coffee consumption and risk of cancers: a meta-Analysis of cohort studies. BMC Cancer 11, 96, 2011. doi:10.1186/1471-2407-11-96
10. Nilsson LM, Johansson I, Lenner P, Lindahl B, and Van Guelpen B: Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21, 1533-1544, 2010. doi:10.1007/s10552-010-9582-x
11. Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, et al.: Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 103, 876-84, 2011. doi:10.1093/jnci/djr151
12. Shafique K, McLoone P, Qureshi K, Leung H, Hart C, et al.: Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 11, 42, 2012. doi:10.1186/1475-2891-11-42
13. Bosire C, Stampfer MJ, Subar AF, Wilson KM, Park Y, et al.: Coffee consumption and the risk of overall and fatal prostate cancer in the NIHAARP Diet and Health Study. Cancer Causes Control 24, 1527-1534, 2013. doi:10.1007/s10552-013-0229-6
14. Discacciati A, Orsini N, Andersson SO, Andren O, Johansson JE, et al.: Coffee consumption and risk of localized, advanced and fatal prostate cancer: a population-based prospective study. Ann Oncol 24, 1912-1918, 2013. doi:10.1093/annonc/mdt105
15. Li Q, Kakizaki M, Sugawara Y, Tomata Y, Watanabe T, et al.: Coffee consumption and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 108, 2381-2389, 2013. doi:10.1038/bjc.2013.238
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al.: Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008-2012, 2000.
17. Severson RK, Nomura AM, Grove JS, and Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49, 1857-1860, 1989.
18. Ellison LF: Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9, 125-130, 2000.
19. Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, et al.: A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15, 911-920, 2004. doi:10.1007/s10552-004-1683-y
20. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-Analysis. Stat Med 21, 1539-1558, 2002. doi:10.1002/sim.1186
21. Hedges LV and Pigott TD: The power of statistical tests for moderators in meta-Analysis. Psychol Methods 9, 426-445, 2004. doi:10.1037/1082-989x.9.4.426
22. Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101, 1994.
23. Egger M and Smith GD: Bias in location and selection of studies. BMJ 316, 61-66, 1998.
24. Orsini N, Li R, Wolk A, Khudyakov P, and Spiegelman D: Meta-Analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73, 2012. doi:10.1093/aje/kwr265
25. Orsini NBR and Greenland S: Generalized least squares for trend estimation of summarized dose-respose data. Stata J 6, 40-57, 2006.
26. Jackson D, White IR, and Thompson SG: Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-Analyses. Stat Med 29, 1282-1297, 2010. doi:10.1002/sim.3602
27. Greenland S and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-Analysis. Am J Epidemiol 135, 1301-1309, 1992.
28. Jacobsen BK, Bjelke E, Kvale G, and Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76, 823-831, 1986.
29. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, et al.: Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res 50, 6836-6840, 1990.
30. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, and Hirohata T: Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5, 276-282, 1994.
31. Stensvold I and Jacobsen BK: Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5, 401-408, 1994.
32. Sang LX, Chang B, Li XH, and Jiang M: Consumption of coffee associated with reduced risk of liver cancer: a meta-Analysis. BMC Gastroenterol 13, 34, 2013. doi:10.1186/1471-230x-13-34
33. Dong J, Zou J, and Yu XF: Coffee drinking and pancreatic cancer risk: a meta-Analysis of cohort studies. World J Gastroenterol 17, 1204-1210, 2011. doi:10.3748/wjg.v17.i9.1204
34. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 1767-1776, 1995.
35. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, and Willett WC: Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6, 557-563, 1997.
36. Platz EA, Rimm EB, Willett WC, Kantoff PW, and Giovannucci E: Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92, 2009-2017, 2000.
37. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, et al.: Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 275, 458-462, 1996.
38. Leviton A and Cowan L: A review of the literature relating caffeine consumption by women to their risk of reproductive hazards. Food Chem Toxicol 40, 1271-310, 2002.
39. Miura Y, Ono K, Okauchi R, and Yagasaki K: Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats. J Nutr Sci Vitaminol (Tokyo) 50, 38-44, 2004.
40. Hashimoto T, He Z, Ma WY, Schmid PC, Bode AM, et al.: Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res 64, 3344-3349, 2004.
41. Lee WJ and Zhu BT: Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269-277, 2006. doi:10.1093/carcin/bgi206
42. Asaad NA, Zeng ZC, Guan J, Thacker J, and Iliakis G: Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants. Oncogene 19, 5788-5800, 2000. doi:10.1038/sj. onc.1203953
43. Joerges C, Kuntze I, and Herzinger T: Induction of a caffeine-sensitive Sphase cell cycle checkpoint by psoralen plus ultraviolet A radiation. Oncogene 22, 6119-6128, 2003. doi:10.1038/sj.onc.1206613
44. Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, et al.: Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 7, 176-187, 2011.
45. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, et al.: Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280, 27888-27895, 2005. doi:10.1074/jbc.M503347200